
Panzest 25000300 mg
Everest Pharmaceuticals Ltd.
Pancreatin [High Lipase] is a pancreatic enzyme replacement product formulated with a proportionally higher lipase content relative to its protease and amylase content.
Pancreatin [High Lipase] is a pancreatic enzyme replacement product formulated with a proportionally higher lipase content relative to its protease and amylase content. It is used to improve digestion of dietary fats, proteins, and carbohydrates in patients with exocrine pancreatic insufficiency (EPI), thereby reducing steatorrhea and supporting nutrient absorption.
Certain non-enteric-coated formulations of Pancreatin [High Lipase] are used in combination with an acid-suppressing agent (such as a proton pump inhibitor), as directed by the physician, to protect enzyme activity from inactivation by gastric acid. Pancreatin [High Lipase] is an adjunct to dietary management and does not replace medical nutrition therapy.
Dosing of Pancreatin [High Lipase] is individualized, weight-based, and titrated according to the severity of steatorrhea, dietary fat intake, and clinical response (stool pattern, weight gain, nutritional status). The figures below reflect typical, widely used weight-based dosing ranges for pancreatic enzyme replacement products of this type; the treating physician should set the exact starting dose and titration schedule.
| Population | Typical Starting Dose | Maximum Dose |
|---|---|---|
| Infants (up to 12 months) | 2,000–4,000 lipase units per 120 mL of formula or breast milk | As advised by the physician; monitor growth closely |
| Children 1–4 years | 1,000 lipase units/kg body weight per meal | 2,500 lipase units/kg per meal |
| Children ≥4 years and adults | 500 lipase units/kg body weight per meal | 2,500 lipase units/kg per meal; not to exceed 10,000 lipase units/kg/day or approximately 4,000 lipase units per gram of dietary fat ingested per day |
Half the meal dose is typically given with snacks. Doses above these limits should not be used without specialist supervision because of the risk of fibrosing colonopathy (see Precautions and Warnings).
The most commonly reported side effects of Pancreatin [High Lipase] are gastrointestinal and generally mild:
Pancreatin [High Lipase] is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.